In epidemiological studies, estimation of attack rate indicators such as *R~0~* (i.e., the basic reproduction number of epidemic outbreak) has a special place among health analysts and policymakers to estimate the rate of epidemic.[@ref1] For example, *R~0~* was used in Japan[@ref1] to measure the potential for influenza transmission, H1N1 in 2009.

Although there are different ways to estimate *R~0~.*^2^, one of the most common forms of *R~0~* used in epidemiological studies to estimate epidemic viability is the equation (1),
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where, *AR* is the percentage of the infected population and *S*~0~ is the initial percentage of susceptible population to disease in a target population. According to Equation (1), we find that the value of *S*~0~ cannot be easily estimated, because duration of diseases and susceptible population is exactly unknown.

Therefore, the relatively accurate method for estimating the number of susceptible (*S*~0~) as one of the *R~0~* parameters is very important. However, this estimation in studies is usually not possible and its size is estimated either based on statistical distributions.[@ref3] or determined from previous study information. Both of these strategies may cause a bias in estimating *R~0~*.

Now, the fundamental question is "what is the way to estimate hidden population with covid-19 disease?" Another questions is, "is it possible to estimate coronavirus susceptibility population without screening and spending exorbitant CT-scan and PCR-test costs?"

Several studies[@ref4]-[@ref6] have shown that hidden population can be estimated by the network scale-up method as indirect estimation method. Therefore, we propose a network scale-up method to estimate the hidden population with COVID-19 disease.

For simplicity and adapting to Lotfi's study,[@ref7] we can introduce the steps of estimating the hidden population of people with COVID-19 disease using the following network expansion method:

Estimating the average of respondents' personal network size;Asking the respondents about the number of people they know in the hidden population; *i.e*., the number of people with coronavirus in the hidden population known by respondents; andEstimation of the hidden population size, *i.e*., estimation of people with coronavirus as hidden population.

Bernard et al.[@ref4] showed that the hidden population size can be estimated according to the Equation (2),
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where, *T* is target population or the total number of people living in a geographical area, which is determined by census information, etc.; *e* is the size of the total hidden population in the target group, *i.e*., coronavirus patients; *m* is the average number of people with coronavirus that each person knows on their active social network; and *C* is average of the active social network of respondents.

Now, according to equation (1) what is unknown for us is the size of *S*~0~ (*i.e*., the hidden population with coronavirus), which can be replaced to in equation (2). Thus, we can estimate the indirect estimate of the hidden population with Covid-19 disease using network expansion method according to Equation (3),
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Our proposed method can answer the controversy over the estimation of the hidden population of patients with COVID-19 disease. The network scale-up methods have already been used to estimate the hidden population of drug abuse,[@ref7] size estimation of groups at high risk of HIV/AIDS.[@ref6] Achieving such a population plays an important role in health policy aimed at identifying the burden of the disease within groups and populations.
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